別品名 |
Dynacin, Klinomycin, Minocin, Vectrin, [4S-(4α,4aα,5aα,12aα)]-4,7-Bis(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a- tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride
|
別包装 |
あり
|
純度 |
>=98%
|
分子量 |
493.94
|
CAS RN® |
13614-98-7
|
化合物の概要 |
Tetracycline; protein translation inhibitor, MMP inhibitor.
|
構造 |
C23H27N3O7 HCl
|
溶媒 |
Soluble in dilute acids or bases.
|
使用目的 |
Minocycline is a tetracycline antibiotic and antifungal compound that also displays neuroprotective, immunosuppressive, and chemotherpaeutic activity. Minocycline acts as a bacteriostatic antimicrobial, inhibiting protein synthesis of gram positive and gram negative bacteria. This compound inhibits matrix metalloproteinases and reduces hemorrhagic transformation after stroke and also attenuates isofluorane-induced cognitive impairment in animal models. Additionally, minocycline inhibits NF-κB and T cell signaling as well as microglial activity and the enzyme 5-lipoxygenase, improving symptoms of psychiatric and immune disorders. Minocycline inhibits IL-6 expression, downregulates the IL-6 receptor system, and decreases expression of phosphorylated STAT3, phosphorylated ERK1/2, MCL-1, and matrix metalloproteinases 2 and 9 in ovarian cancer cell lines. This compound also displays benefit in an animal model of ALS, inhibiting cytochrome c release and delaying disease progression.
|
その他 |
[外観]Yellow Crystals
|
参考文献 |
Mora M, Medina-Leendertz SJ, Bonilla E, et al. Minocycline, but not ascorbic acid, increases motor activity and extends the life span of Drosophila melanogaster. Invest Clin. 2013 Jun;54(2):161-70. PMID: 23947005.Blacker DJ, Prentice D, Alvaro A, et al. Reducing haemorrhagic transformation after thrombolysis for stroke: a strategy utilising minocycline. Stroke Res Treat. 2013;2013:362961. PMID: 23691430.Kong F, Chen S, Cheng Y, et al. Minocycline attenuates cognitive impairment induced by isoflurane anesthesia in aged rats. PLoS One. 2013 Apr 17;8(4):e61385. PMID: 23613842.Watabe M, Kato TA, Tsuboi S, et al. Minocycline, a microglial inhibitor, reduces 'honey trap' risk in human economic exchange. Sci Rep. 2013;3:1685. PMID: 23595250.Ataie-Kachoie P, Morris DL, Pourgholami MH. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies. PLoS One. 2013 Apr 8;8(4):e60817. PMID: 23593315.Giuliani F, Hader W, Yong VW. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol. 2005 Jul;78(1):135-43. PMID: 15817702.Song Y, Wei EQ, Zhang WP, et al. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport. 2004 Oct 5;15(14):2181-4. PMID: 15371729.Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002 May 2;417(6884):74-8. PMID: 11986668.Waterworth PM. The effect of minocycline on Candida albicans. J Clin Pathol. 1974 Apr;27(4):269-72. PMID: 4212409.
|
※サムネイル画像をクリックすると拡大画像が表示されます。
|
|
|
メーカー |
品番 |
包装 |
LKT
|
M3353
|
500 MG
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
1週間程度
|
保存温度 |
4℃
|
|